Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.
α active specific immunotherapy aims at stimulating the host's immune system to recognize and eradicate malignant cells. The concomitant activation of dendritic cells (DC) and natural killer (NK) cells is an attractive modality for immune-based therapies. Inducing immunogenic cell death to faci...
Guardado en:
Autores principales: | Eva Lion, Sébastien Anguille, Zwi N Berneman, Evelien L J M Smits, Viggo F I Van Tendeloo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af87beb1555644ce8817074f2c6565a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Interleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.
por: Sébastien Anguille, et al.
Publicado: (2012) -
NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface
por: Sandra M. Blois, et al.
Publicado: (2017) -
CD123-Targeted Nano-Curcumin Molecule Enhances Cytotoxic Efficacy in Leukemic Stem Cells
por: Wariya Nirachonkul, et al.
Publicado: (2021) -
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
por: Yu Hui Kang, et al.
Publicado: (2019) -
Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics
por: Lars Velten, et al.
Publicado: (2021)